North Rock Partners, LLC Edwards Lifesciences Corp Transaction History

North Rock Partners, LLC

  • $1.16 Billion
  • Q2 2024

A detailed history of North Rock Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, North Rock Partners, LLC holds 11,658 shares of EW stock, worth $759,635. This represents 0.09% of its overall portfolio holdings.

Number of Shares
11,658
Previous 13,847 15.81%
Holding current value
$759,635
Previous $1.32 Million 18.67%
% of portfolio
0.09%
Previous 0.11%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024
SELL
$84.3 - $94.31 $184,532 - $206,444
-2,189 Reduced 15.81%
11,658 $1.08 Million
Q1 2024

May 07, 2024
BUY
$72.54 - $95.56 $51,068 - $67,274
704 Added 5.36%
13,847 $1.32 Million
Q4 2023

Feb 08, 2024
SELL
$61.71 - $77.76 $22,153 - $27,915
-359 Reduced 2.66%
13,143 $1 Million
Q3 2023

Oct 24, 2023
SELL
$69.28 - $93.38 $79,949 - $107,760
-1,154 Reduced 7.87%
13,502 $935,000
Q2 2023

Aug 02, 2023
SELL
$81.41 - $94.33 $42,903 - $49,711
-527 Reduced 3.47%
14,656 $1.38 Million
Q1 2023

May 03, 2023
BUY
$74.26 - $84.51 $71,141 - $80,960
958 Added 6.73%
15,183 $1.26 Million
Q4 2022

Feb 01, 2023
SELL
$68.3 - $87.44 $83,326 - $106,676
-1,220 Reduced 7.9%
14,225 $1.06 Million
Q3 2022

Nov 02, 2022
SELL
$82.37 - $107.29 $49,010 - $63,837
-595 Reduced 3.71%
15,445 $1.28 Million
Q2 2022

Aug 04, 2022
BUY
$86.5 - $128.27 $151,634 - $224,857
1,753 Added 12.27%
16,040 $1.53 Million
Q1 2022

May 05, 2022
SELL
$101.96 - $128.34 $281,103 - $353,833
-2,757 Reduced 16.18%
14,287 $1.68 Million
Q4 2021

Feb 07, 2022
BUY
$106.37 - $130.68 $40,739 - $50,050
383 Added 2.3%
17,044 $2.21 Million
Q3 2021

Nov 12, 2021
BUY
$102.91 - $122.75 $84,797 - $101,146
824 Added 5.2%
16,661 $1.89 Million
Q2 2021

Aug 12, 2021
SELL
$83.84 - $104.76 $112,848 - $141,006
-1,346 Reduced 7.83%
15,837 $1.64 Million
Q1 2021

May 11, 2021
SELL
$78.68 - $90.67 $13,218 - $15,232
-168 Reduced 0.97%
17,183 $1.44 Million
Q4 2020

Feb 08, 2021
SELL
$71.69 - $91.23 $103,376 - $131,553
-1,442 Reduced 7.67%
17,351 $1.58 Million
Q3 2020

Nov 12, 2020
BUY
$67.19 - $87.44 $16,327 - $21,247
243 Added 1.31%
18,793 $1.5 Million
Q2 2020

Aug 13, 2020
SELL
$57.54 - $76.95 $115 - $153
-2 Reduced 0.01%
18,550 $1.28 Million
Q2 2020

Aug 11, 2020
BUY
$57.54 - $76.95 $709,122 - $948,331
12,324 Added 197.88%
18,552 $1.28 Million
Q1 2020

May 13, 2020
SELL
$52.41 - $81.0 $5,607 - $8,667
-107 Reduced 1.69%
6,228 $1.18 Million
Q4 2019

Feb 12, 2020
SELL
$71.7 - $82.09 $71 - $82
-1 Reduced 0.02%
6,335 $1.48 Million
Q4 2019

Feb 12, 2020
BUY
$71.7 - $82.09 $55,710 - $63,783
777 Added 13.98%
6,336 $1.48 Million
Q3 2019

Nov 12, 2019
BUY
$61.55 - $75.43 $342,156 - $419,315
5,559 New
5,559 $1.22 Million

Others Institutions Holding EW

# of Institutions
1,418
Shares Held
470M
Call Options Held
2.44M
Put Options Held
2.65M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email